Atlas Venture Life Science Advisors, LLC Avrobio, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $799 Million
- Q1 2024
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Avrobio, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 4,541,381 shares of AVRO stock, worth $6.72 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
4,541,381
Previous 4,541,381
-0.0%
Holding current value
$6.72 Million
Previous $6.18 Million
5.89%
% of portfolio
0.73%
Previous 0.97%
Shares
2 transactions
Others Institutions Holding AVRO
# of Institutions
49Shares Held
28.1MCall Options Held
9KPut Options Held
100-
Bml Capital Management, LLC Zionsville, IN4MShares$5.92 Million3.43% of portfolio
-
Adar1 Capital Management, LLC Austin, TX3.95MShares$5.85 Million1.15% of portfolio
-
Verition Fund Management LLC Greenwich, CT1.93MShares$2.85 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$2.78 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.24MShares$1.83 Million0.01% of portfolio
About AVROBIO, Inc.
- Ticker AVRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,773,900
- Market Cap $64.8M
- Description
- AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...